Skip to content

Respiratory Proprioceptive Neuromuscular Facilitation Technique in Chronic Pulmonary Obstructive Disease Patients.

Effects of Respiratory Proprioceptive Neuromuscular Facilitation (PNF) Technique on Pulmonary Function of Chronic Pulmonary Obstructive Disease (COPD) Patients.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05876403
Acronym
COPD
Enrollment
56
Registered
2023-05-25
Start date
2023-09-01
Completion date
2023-12-15
Last updated
2024-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD

Keywords

Peak Expiratory Flow Rate (PEFR), Pulmonary function, PNF techniques

Brief summary

The purpose of this study is to evaluate the impact of PNF technique combined with aerobic exercises among COPD patients in a clinical setting. Previous literature has evaluated this technique in ventilated patients but in clinical setting specifically in Pakistan, this invention therapy has not been implied in COPD patients.

Detailed description

Chronic Obstructive Pulmonary Disorder manifested as breathlessness, respiratory difficulties and persistent cough is one of the biggest causes of mortality around the world. 2.1% of Pakistani population has COPD. Proprioceptive neuromuscular facilitation is used as management technique in which muscle stretching promotes chest wall mobility and restores regular breathing rhythm. In previous studies, PNF technique combined with aerobic exercises has been utilized to improve Pulmonary functions in COPD patients. But the sample size of these studies was small and participants were ventilated patients, hence not targeting the diaphragm. Our study shall evaluate the impact of PNF technique combined with aerobic training on the Pulmonary function of COPD patients in the clinical setting.

Interventions

OTHERConventional

The participants of controlled group will be given the treatment protocol after baseline measurements controlled breathing techniques (3session per week 10mins for 6 weeks) & Aerobic exercise(3 session per week for 6 weeks) with 10sec hold into 10reps.outcome measures will be recorded through a digital spirometer & measurement of 6MWT & chest expansion.

OTHERPNF

The participants of experimental group will be given the Intervention protocol after baseline measurements. Additionally these 30 participants will also receive PNF technique exercises consisting of Thoracic Vertebral pressure, Anterior Basal stretch, and Intercostal stretch for 20-25 minutes in 3 sessions per week, and outcomes Measures will be recorded through a digital spirometer and measurements of 6 minutes walk test and chest Expansion.

Sponsors

Riphah International University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
35 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Both male & female participants. * Diagnosed COPD patients * Age 35-60years * Ratio of forced expiratory volume in first second & forced vital capacity(FEV1/FVC \<0.7,30%\<FEV1\<80% * Stable clinical condition.

Exclusion criteria

* Serious conditions with require supplementary oxygen or ventilator/support devices. * COPD exacerbation within last 4weeks * Patients with recent chest wall trauma, surgery or deformity. * Patient with neurological, psychological, musculoskeletal, or cardiac medical history. * Pulmonary disease with physical impairment. * Inability to follow the pulmonary rehabilitation program.

Design outcomes

Primary

MeasureTime frameDescription
Forced expiratory volume in 1sec (FEV1)two weeksForced expiratory volume in 1sec (FEV1) measured through digital spirometer. If the value of FEV1 is within 80% of the reference value, the results are considered normal
Peak expiratory flow rate (PEFR)two weeksPeak expiratory flow rate (PEFR) Peak expiratory flow rate (PEFR) measured through digital spirometer. Peak Expiratory Flow Rate (PEFR) measured through digital spirometer. Three zones of measurement are commonly used to interpret peak flow rates. Normal value of PEFR is (80-100%). Green zone indicates 80 to 100 percent of the usual or normal peak flow reading, yellow zone indicates 50 to 79 percent of the usual or normal peak flow readings, and red zone indicates less than 50 percent of the usual or normal peak flow readings.
Forced vital capacity (FVC)two weeksForced vital capacity (FVC) measured through digital spirometer. If the value of FVC is within 80% of the reference value, the results are considered normal. Changes in FVC from baseline to 5th and after 15th day of intervention will be assessed.
COPD assessment testtwo weeks8 points questionnaire will evaluate patients Pulmonary function capacity through semantic 6 point difference Scale.
Chest Expansiontwo weeksThe expansion of chest during breathing will be measures and axillary, nipple and xiphisternal level using a measuring tape.
Modified Borg Dyspnea Scaletwo weeksParticipants will fill this 12 points Scale to show breathing difficulty from 0 to 10.

Secondary

MeasureTime frameDescription
6 minutes walk test:two weeksThis test with minimum important distance of 25 metres will assess aerobic & functional capacity of participants in a 6 minutes walk.

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026